Cargando…

Super-enhancers: novel target for pancreatic ductal adenocarcinoma

Super-enhancers (SEs) are unique areas of the genome which drive high-level of transcription and play a pivotal role in the cell physiology. Previous studies have established several important genes in cancer as SE-driven oncogenes. It is likely that oncogenes may hack the resident tissue regenerati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Chandrayee, Paul, Santanu, Dandawate, Prasad, Gunewardena, Sumedha S., Subramaniam, Dharmalingam, West, Cameron, Anant, Shrikant, Dhar, Animesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422180/ https://www.ncbi.nlm.nih.gov/pubmed/30899425 http://dx.doi.org/10.18632/oncotarget.26704

Ejemplares similares

DNA Methyltransferases: A Novel Target for Prevention and Therapy
por: Subramaniam, Dharmalingam, et al.
Publicado: (2014)

Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway
por: Dandawate, Prasad, et al.
Publicado: (2020)

Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
por: Angulo, Pablo, et al.
Publicado: (2017)

Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone
por: Krishnamachary, Balaji, et al.
Publicado: (2019)

Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells
por: Ponnurangam, Sivapriya, et al.
Publicado: (2015)

Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells
por: Rangarajan, Parthasarathy, et al.
Publicado: (2015)

Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis
por: Subramaniam, Dharmalingam, et al.
Publicado: (2021)

Suppressing STAT5 signaling affects osteosarcoma growth and stemness
por: Subramaniam, Dharmalingam, et al.
Publicado: (2020)

Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies
por: Standing, David, et al.
Publicado: (2023)

Association of losartan with outcomes in metastatic pancreatic cancer patients treated with chemotherapy
por: Kasi, Anup, et al.
Publicado: (2021)

Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells
por: Ramamoorthy, Prabhu, et al.
Publicado: (2021)

Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer
por: Escher, Taylor E., et al.
Publicado: (2021)

Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
por: Li, Yan, et al.
Publicado: (2022)

3508 Ciclopirox Olamine Demonstrates Inhibitory Effects on Esophageal Tumor Cells
por: Ryan, Randi, et al.
Publicado: (2019)

Targeting Super‐Enhancers via Nanoparticle‐Facilitated BRD4 and CDK7 Inhibitors Synergistically Suppresses Pancreatic Ductal Adenocarcinoma
por: Huang, Chen‐Song, et al.
Publicado: (2020)

Diffuse-Type Pancreatic Ductal Adenocarcinoma Mimicking Autoimmune Pancreatitis
por: Chow, Kenneth W., et al.
Publicado: (2023)

Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)—basis and current status
por: Ramaswamy, Anant, et al.
Publicado: (2022)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
por: Sikdar, Nilabja, et al.
Publicado: (2018)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Apoptotic pathways in pancreatic ductal adenocarcinoma
por: Hamacher, Rainer, et al.
Publicado: (2008)

Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly
por: Kang, Chang Moo, et al.
Publicado: (2007)

Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
por: Ottenhof, Niki A., et al.
Publicado: (2011)

Mast cells in pancreatic ductal adenocarcinoma
por: Chang, David Z.
Publicado: (2012)

Genetics and biology of pancreatic ductal adenocarcinoma
por: Ying, Haoqiang, et al.
Publicado: (2016)

Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
por: Li, Junjie, et al.
Publicado: (2016)

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
por: Melzer, Michael Karl, et al.
Publicado: (2020)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Anderson, Eric M., et al.
Publicado: (2021)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
por: Satoi, Sohei
Publicado: (2021)

Advances in the management of pancreatic ductal adenocarcinoma
por: O’Kane, Grainne M., et al.
Publicado: (2021)

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
por: Karimnia, Vida, et al.
Publicado: (2021)

Laparoscopic pancreaticoduodenectomy in pancreatic ductal adenocarcinoma
por: Choi, Munseok, et al.
Publicado: (2021)

Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
por: Wei, Kongyuan, et al.
Publicado: (2021)

Oral mycobiota and pancreatic ductal adenocarcinoma
por: Wei, Ailin, et al.
Publicado: (2022)

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
por: Chouari, Tarak, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sik3br6u23bi4o9arqtatuh24q